Plantation forestry with exotic trees in south China needs compatible symbionts to improve the growth of seedlings in nurseries and to enhance establishment and growth in the field. Scleroderma, a potentially suitable symbiont for inoculation, is not being used in containerized nurseries in the region due to poor knowledge of its host range. The ability of 15 collections of Scleroderma, nine from Australia and six from Asia, to colonize and promote growth of four important exotic plantation trees (Eucalyptus globulus Labill., Eucalyptus urophylla ST Blake, Pinus elliottii Engl., and Pinus radiata D. Don) was examined in a nursery potting mix. There was generally low host specificity of Scleroderma between tree genera. At 12 weeks after inoculation, 13 to 14 of the 15 spore collections formed ectomycorrhizas on seedlings of eucalypts or pines. The extent of colonization differed between spore treatments with two or four collections forming abundant mycorrhizas (>50% fine roots colonized) on E. globulus or E. urophylla, respectively, and three or five on P. radiata or P. elliottii, respectively. Three collections from Australia strongly colonized all hosts resulting in 26 to 100% of short roots being colonized. Chinese Scleroderma collections resulted in fewer mycorrhizas on eucalypts than on pines. Inoculation stimulated the growth (shoot height and dry weight) of eucalypt and pine seedlings by up to 105% where Scleroderma mycorrhizas developed. The results suggest that there is a need to source Scleroderma from outside China for inoculating eucalypts in Chinese nurseries whereas Chinese collections of Scleroderma could be used in pine nurseries. Further screening of Australian and Chinese Scleroderma should be performed in Chinese nurseries and in the field before final commercial decisions are made.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00572-006-0039-8DOI Listing

Publication Analysis

Top Keywords

scleroderma
9
south china
8
growth exotic
8
eucalyptus globulus
8
globulus urophylla
8
pinus elliottii
8
collections scleroderma
8
eucalypts pines
8
roots colonized
8
chinese scleroderma
8

Similar Publications

This 30-color panel was developed to enable the enumeration and purification of distinct circulating immune cell subsets implicated in the pathogenesis of systemic autoimmune diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc; scleroderma), Sjögren's disease (SjD), idiopathic inflammatory myopathy (IIM), and others. While designed for application to peripheral blood mononuclear cells, the inclusion of CD45 coupled with the ability to extract cellular autofluorescence spectral signatures enables the application of this panel to other tissue types. Of the 30 total markers, this panel employs 18 markers to profile T cell subsets consisting of different memory subsets and T helper polarities, > 10 markers to profile B cell subsets including double-negative B cells, and a total of 8 lineage markers to identify immune lineages including monocyte and natural killer cell subsets, conventional dendritic cells, plasmacytoid dendritic cells, and basophils.

View Article and Find Full Text PDF

Systemic sclerosis sine (latin: without) scleroderma (ssSSc), also called visceral scleroderma, is characterized by internal organ involvement and abnormal serologic abnormalities in the complete or partial absence of cutaneous manifestations of systemic sclerosis.1,2 Pulmonary involvement in scleroderma consists of interstitial lung disease and pulmonary hypertension. Usual interstitial pneumonia (45.

View Article and Find Full Text PDF

Systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and idiopathic inflammatory myositis (IIM) are autoimmune diseases managed with long-term immunosuppressive therapies. Hu19-CD828Z, a fully human anti-CD19 chimeric antigen receptor (CAR) with a CD28 costimulatory domain, is engineered to potently deplete B-cells. In this study, we manufactured Hu19-CD828Z CAR T-cells from peripheral blood of SLE, IIM, and SSc patients and healthy donors (HDs).

View Article and Find Full Text PDF

Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions.

Medicina (Kaunas)

December 2024

Department of Rheumatology and Physiotherapy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.

Systemic sclerosis (SSc) is an immuno-inflammatory rheumatic disease that can affect both the skin and internal organs through fibrosis. Pulmonary arterial hypertension (PAH) is one of the most severe secondary complications. Structural changes in the vascular bed lead to increased pressures in the pulmonary circulation, severely impacting the right heart and significantly affecting mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!